Source: BioSpace Almirall acquired a minority stake in US based company ThermiGen LLC and plans to close the complete acquisition of ThermiGen by January 31st, 2016. First step towards building a presence in the aesthetics market that helps to further consolidate its strategy in Dermatology. The potential acquisition would provide…...
Anacor Pharmaceuticals to Present Data From Long-Term Safety Study of Crisaborole Topical Ointment, 2% in Patients With Mild-to-Moderate Atopic Dermatitis at Upcoming Medical Conference
Source: Anacor Pharmaceuticals, Inc. (ANAC) announced today that it will present data from the long-term safety study of crisaborole topical ointment, 2% in children and adults with mild-to-moderate atopic dermatitis at the Winter Clinical Dermatology Conference, being held in Koloa, Hawaii from January 15-20, 2016. About Crisaborole Topical Ointment, 2%…...
Valeant Names Howard Schiller as Interim CEO
Source: USA Today Valeant Pharmaceuticals International, the Canadian drugmaker whose CEO has been on medical leave while it faces congressional scrutiny over its pricing practices, said Wednesday it appointed Howard B. Schiller as interim CEO, effective immediately. Schiller, who joined Valeant as COO in 2009 after a 24-year career at…...